Latest Breaking News On - ஸ்பாட்லைட் அமர்வு - Page 1 : comparemela.com
07 14 21 -- How Clinical Trials Execs Adapted To The Pandemic s Digital Demands
clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.
Crowder Tops Billboard Christian Albums Chart for 3rd Time with Latest Release Milk & Honey
breathecast.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from breathecast.com Daily Mail and Mail on Sunday newspapers.
Seven key takeaways from joining Aseptic Processing Conference in September 2021
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Canela.TV to Host First-Ever Upfront Presentation Unveiling New Ways for Brands to Activate Hispanic Audiences
Share Article
Presentation to showcase unique first-to-market offerings available on popular Hispanic AVOD streaming platform.
We are tremendously excited to be joining the virtual Upfront stage this year for the first time to showcase our approach to Hispanic-focused streaming NEW YORK (PRWEB) April 28, 2021
Canela.TV, one of the first AVOD streaming services for U.S. Hispanics, will host its first-ever upfront presentation themed “We Make It Happen / Lo Hacemos Posible” on May 17th at 3:00 pm ET. Hosted by Canela Media’s founder and CEO Isabel Rafferty, the virtual upfront will reveal the exciting developments on Canela.TV’s slate for 2021 and beyond and showcase how advertisers can tap into the diversity and scale of Hispanic audiences. Canela.TV’s platform was built exclusively for Latinos
04.07.21 AI Speeds Patient Recruitment At Health Quest
On this episode of
Business of Biotech, Nevan Charles Elam, J.D., founder of Rezolute Bio, shares the company s rationale for pursuing congenital hyperinsulinism and diabetic macular edema therapeutics by leveraging monoclonal antibodies (mAbs) and discusses the company s approach to process development and manufacturing. Listen now and subscribe so you never miss an episode.
Featured Editorial
By Ed Miseta, chief editor, Clinical Leader
Artificial intelligence (AI) has the potential to disrupt and revolutionize many aspects of clinical trials. One area in which it is already making an impact is patient recruitment. Mining electronic medical records (EMRs) for patients meeting inclusion and exclusion criteria can be tedious and time-consuming work but is a chore that seems ideal for an AI solution.